SPECTROPHOTOMETRIC DETERMINATION OF AN ANTIDIABETIC DRUG SAROGLITAZAR BULK AND PHARMACEUTICAL FORMULATIONS
Manjusha D. Karad and Dr. V. D. Barhate*
ABSTRACT
A new, simple, precise ,sensitive, accurate, and reproducible
spectrophotometric method for the determination of saroglitazar in
pure and in capsule dosage form is described. The method is based on
the oxidation of the drug with alkaline potassium permanganate at
room temperature. The absorbance of the green colored manganate
ions produced is measured at 600nm. Beer’s law is obeyed in the
concentration range of 0.5-3.0 μg/mL for the developed method. The
molar absorptivity and sandell sensitivity are found to be 73313.78 L
mol-1cm-1and 0.0060 μg/cm2 respectively. The regression equation for
saroglitazar was found to be y = 0.152X + 0.021 and the
correlation coefficient for the regression line was 0.9995. Different
experimental parameters affecting the color development and stability
of colored product are carefully studied and optimized. The developed method could be
successfully applied to pharmaceutical formulations. The results obtained are in good
agreement with those obtained using standard Method.
Keywords: Saroglitazar, Spectrophotometric method, KMnO4, LIPAGLYN Marketed formulation.
[Download Article]
[Download Certifiate]